Premium
Invictus MD Strategies Corporation (CE) (IVITF)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Invictus announces Annual General Meeting Date Vancouver, BC, Canada -- June 20, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the...
Update On Acreage Pharms Ltd.Vancouver, BC, Canada -- June 12, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE;...
Invictus announces APPOINTMENT to Board Vancouver, BC, Canada -- June 11, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company"...
Invictus announces Executive Appointment Vancouver, BC, Canada -- June 5, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV:...
Invictus announces changes to Board Vancouver, BC, Canada -- June 4, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX:...
Vancouver, BC, CANADA -- May 31, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:...
Invictus Withdraws Plans for NASDAQ Listing and Related ShareConsolidation Vancouver, BC, Canada -- May 15, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP...
Invictus Announces Appointment Of Director And Chief Operating Officer Vancouver, BC, Canada -- May 9, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the...
Vancouver, BC -- February 13, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is...
Vancouver, BC -- January 28, 2019 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 0 | 0 | CS |
| 156 | -9.9E-5 | -99 | 0.0001 | 0.001 | 1.0E-6 | 8046 | 2.21E-5 | CS |
| 260 | -0.079999 | -99.99875 | 0.08 | 0.1466 | 1.0E-6 | 94164 | 0.03337126 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
